Global COPD Drugs Market Forecast to 2023 COPD Market Report | Page 17

List of Figures
Figure No.
Figure Title
Page No.
Figure 101: Germany, Spending on Healthcare, 2015 & 2040E, (USD Per Person) 105
Figure 102: Germany, Healthcare Related Statistics, 2017 105
Figure 103: Germany, Smoking Prevalence, Age 15+, 2012-2016, (% of Total) 106
Figure 104: Germany, Percentage Change In Cause of Death Between 2007-2017 106
Figure 105: Germany COPD Drugs Market Size, By Drug Type, 2017 (%) 107
Figure 106: Germany COPD Drugs 107
Figure 107: Germany COPD Drugs Market, By Drug Type, By Value, 2013-2017 (USD Million) 108
Figure 108: France COPD Drugs Market, By Value, 2013-2017 (USD Million) 110
Figure 109: France COPD Drugs Market, By Value, 2018-2023(USD Million) 110
Figure 110: France, COPD Prevalence, 2013-2017, 2018E-20123E, (in Millions) 111
Figure 111: France, Smoking Prevalence, Age 15+, 2012-2017, (% of Total) 112
Figure 112: France, Healthcare Infrastructure Related Statistics 112
Figure 113: France, PM2.5 air pollution, mean annual exposure (micrograms per cubic meter), 2017 112
Figure 114: France, Health Expenditure, (% of GDP), 2012-2015 (USD) 113
Figure 115: France, Population Ages 65 and Above (% of total), 2012-2017 113
Figure 116: France, Cause of Death, 2017, (% of Total) 113
Figure 117: France, Spending on Healthcare, 2015 & 2040, (USD Per Person) 113
Figure 118: France COPD Drugs Market Size, By Drug Type, 2017 (%) 114
Figure 119: France COPD Drugs 114
Figure 120: France COPD Drugs Market, By Drug Type, By Value, 2013-2017 (USD Million)
Market Size, By Drug Type, 2023F (%)
Market Size, By Drug Type, 2023F (%)
(c) AZOTH Analytics
115
17